InvestorsHub Logo

DonDonDonDon

12/21/20 3:00 PM

#32739 RE: Vanilla Fitbit #32736

The mainstream media doesn't cover drugs being trialed. We will get plenty of media if an EUA is granted by the FDA. But we need a completed trial. The FDA wants completed studies to give approval. None of the Covid drugs unblinded their data at the interim analysis. Unblinding would have satisfied your curiosity but unblinding would not have helped get FDA approval.

go_wamu

12/21/20 3:02 PM

#32741 RE: Vanilla Fitbit #32736

To whom are you asking these questions ?
Make your own DD and try to answer the questions yourself!
... and moderate yourself, it will be of advantage for you too certainly!

4running

12/21/20 3:59 PM

#32756 RE: Vanilla Fitbit #32736

Fitbit, see responses.

Why not unblind? (to ensure any refusal or delay)

Why do absolutely ZERO real media? (Media doesn't help right now with being so heavily politicized)

Why the complete SILENCE? (Complete silence? There are several factual PR's)

Why, with what I AGREE is amazing EAP data etc, why does NO ONE KNOW RLF EXISTS? (On what basis does no one know? - I have communicated with several pulmonologists/Resp Therapists that are aware, and like any scientist, data prevails)

Why NO word from FDA on what should have been the easiest EUA ever? It’s for a patient population that is already approved to get RLF through EAP???? That one BLOWS MY MIND... 96 days that the FDA would rather let 3000 people die a day then approve RLF EUA????!
(You would have to ask the FDA, RLF/NRX is doing the extra credit in between RCT readout to ensure higher volume and less likelihood of further delay, in addition expanding on further indications)


How many of those people could be saved? (Lots of people could be, but bringing the drug to mass market with the RCT outcomes is what medical professionals care about)